Baillie Gifford & Co’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-340	Closed	-$12K	–	333
2023 Q1	$12K	Hold	340	–	–	﹤0.01%	384
2022 Q4	$15.6K	Hold	340	–	–	﹤0.01%	367
2022 Q3	$16K	Hold	340	–	–	﹤0.01%	356
2022 Q2	$13K	Buy	+340	New	+$13K	﹤0.01%	385